|
|||||
|
|
Skeletal Metastases in Pancreatic Cancer: A Retrospective Study and Review of the Literature |
|
| Authors: | Mitesh J. Borad Hamid Saadati Arun Lakshmipathy Elizabeth Campbell Patricia Hopper Gayle Jameson Daniel D. Von Hoff M. Wasif Saif |
| Abstract: | Background: Skeletal metastases represent an underappreciated site of metastasis in patients with pancreatic cancer. Previous reports have estimated the prevalence to range from 5 percent to 20 percent. With the use of gemcitabine and novel targeted agents such as erlotinib, there has been a modest increase in survival in patients with advanced pancreatic cancer. As such, it is anticipated that previously uncommon occurrences such as skeletal metastases will become more frequent. |
| Keywords: | |